Global Statistics

All countries
531,222,652
Confirmed
Updated on May 28, 2022 8:08 pm
All countries
487,603,037
Recovered
Updated on May 28, 2022 8:08 pm
All countries
6,310,242
Deaths
Updated on May 28, 2022 8:08 pm
Saturday, May 28, 2022

Global Statistics

All countries
531,222,652
Confirmed
Updated on May 28, 2022 8:08 pm
All countries
487,603,037
Recovered
Updated on May 28, 2022 8:08 pm
All countries
6,310,242
Deaths
Updated on May 28, 2022 8:08 pm
Molderizer and Safe Shield

COVID-19 treatment, Keytruda boost Merck in 1Q – The Mercury

Pandemic Updates From Readers – The New York Times

Pandemic Updates From Readers  The New York Times Source link

SD County’s COVID-19 Hospitalizations Increase By 6 to 176

A medical staff member treats a patient suffering from the coronavirus disease COVID-19 in the Intensive Care Unit at Scripps Mercy Hospital in...

Occupational burnout in Iranian health care workers during the COVID-19 pandemic | BMC Psychiatry

WHO Coronavirus Disease (COVID-19) Dashboard Data last updated: 2021/08/07. https://covid19.who.int/.Wan Z, Lian M, Ma H, Cai Z, Xianyu Y. Factors associated with burnout...

Coronavirus: Study links COVID to impaired heart function and warns to focus on early signs

For those who have had COVID, an effect on heart problems can complicate the recovery. Though COVID is primarily a respiratory problem, the...

Covid-weary Americans enter Memorial Day with little effort to contain a still-raging pandemic

Placeholder while article actions loadFor the third year, Americans are greeting the unofficial start of summer shadowed by the specter of the coronavirus...


By TOM MURPHY

Merck soared past first-quarter expectations, helped by sales of its long-standing blockbuster cancer drug Keytruda and a new COVID-19 treatment that also topped forecasts.

The drugmaker raised its 2022 forecast Thursday after its coronavirus capsule treatment Lagevrio brought in almost $3.2 billion in sales in the quarter.

Analysts were expecting $2.54 billion from the drug, which debuted late last year under the name molnupiravir.

Not counting Lagevrio, Merck said its pharmaceutical revenue still grew 18% in the first quarter. Sales of Keytruda climbed 23% to $4.81 billion.

Analysts were expecting $4.47 billion, according to a survey by FactSet.

Revenue from the company’s Gardasil vaccines, which protect against cancer-causing human papilloma virus infections, jumped 59% to $1.5 billion, helped by growth in China.

Overall, Merck’s profit climbed 36% to $4.31 billion.

Adjusted earnings, which exclude one-time items, totaled $2.14 per share, while total sales jumped 50% to $15.9 billion.

Analysts expected, on average , earnings of $1.83 per share on about $14.55 billion in revenue in the quarter.

The company also said Thursday it was raising and narrowing its forecast for the year. Merck now expects adjusted earnings to range between $7.24 and $7.36 per share after forecasting $7.12 to $7.27 per share in February.

Analysts expect earnings of $7.28 per share, according to FactSet.

Lagevrio, made by Merck and Ridgeback Biotherapeutics, is one of two pill treatments for COVID-19 that are aimed at treating patients most at risk of winding up in a hospital from the virus.

U.S. regulators approved Lagevrio and Pfizer’s Paxlovid in December, and Merck produced 10 million courses of its treatment by the end of 2021. It plans to add an additional 20 million in 2022.

The drugmaker said in February that it had produced about 3.1 million courses for the U.S. government. The U.S. agreed to pay roughly $700 per course for those treatments.

The COVID-19 treatment is free to patients in the U.S.

Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction.

In clinical trials, Lagevrio reduced hospitalization and death by 30% among adults infected with the coronavirus, when compared with adults taking a placebo or fake drug.

Shares of Merck & Co. Inc., based in Kenilworth, New Jersey, climbed before the opening bell Thursday.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Pandemic Updates From Readers – The New York Times

Pandemic Updates From Readers  The New York Times Source link

SD County’s COVID-19 Hospitalizations Increase By 6 to 176

A medical staff member treats a patient suffering from the coronavirus disease COVID-19 in the Intensive Care Unit at Scripps Mercy Hospital in...

Occupational burnout in Iranian health care workers during the COVID-19 pandemic | BMC Psychiatry

WHO Coronavirus Disease (COVID-19) Dashboard Data last updated: 2021/08/07. https://covid19.who.int/.Wan Z, Lian M, Ma H, Cai Z, Xianyu Y. Factors associated with burnout...

Related Articles

Pandemic Updates From Readers – The New York Times

Pandemic Updates From Readers  The New York Times Source link

SD County’s COVID-19 Hospitalizations Increase By 6 to 176

A medical staff member treats a patient suffering from the coronavirus disease COVID-19 in the Intensive Care Unit at Scripps Mercy Hospital in...

Occupational burnout in Iranian health care workers during the COVID-19 pandemic | BMC Psychiatry

WHO Coronavirus Disease (COVID-19) Dashboard Data last updated: 2021/08/07. https://covid19.who.int/.Wan Z, Lian M, Ma H, Cai Z, Xianyu Y. Factors associated with burnout...